Philadelphia Trust Company’s Elanco Animal Health ELAN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.52M	Sell	188,823 -14,487	-7%	-$354K	0.32%	57
2025 Q4	$4.6M	Sell	203,310 -12,423	-6%	-$270K	0.32%	59
2025 Q3	$4.34M	Sell	215,733 -21,805	-9%	-$365K	0.31%	60
2025 Q2	$3.39M	Buy	237,538 +6,642	+3%	+$77.6K	0.26%	65
2025 Q1	$2.42M	Sell	230,896 -87,334	-27%	-$988K	0.21%	75
2024 Q4	$3.85M	Sell	318,230 -34,132	-10%	-$447K	0.28%	67
2024 Q3	$5.18M	Buy	352,362 +34,563	+11%	+$482K	0.38%	58
2024 Q2	$4.59M	Buy	317,799 +23,132	+8%	+$370K	0.36%	59
2024 Q1	$4.8M	Buy	294,667 +4,361	+2%	+$68.2K	0.39%	61
2023 Q4	$4.33M	Buy	290,306 +31,780	+12%	+$360K	0.41%	61
2023 Q3	$2.91M	Sell	258,526 -35,975	-12%	-$418K	0.3%	73
2023 Q2	$2.96M	Buy	294,501 +5,725	+2%	+$53.1K	0.28%	75
2023 Q1	$2.71M	Buy	288,776 +37,880	+15%	+$447K	0.28%	83
2022 Q4	$3.07M	Sell	250,896 -24,850	-9%	-$310K	0.33%	77
2022 Q3	$3.42M	Buy	275,746 +116,146	+73%	+$2.03M	0.39%	61
2022 Q2	$3.13M	Sell	159,600 -28,135	-15%	-$666K	0.32%	71
2022 Q1	$4.9M	Buy	187,735 +17,035	+10%	+$454K	0.39%	61
2021 Q4	$4.84M	Sell	170,700 -11,325	-6%	-$352K	0.35%	59
2021 Q3	$5.8M	Sell	182,025 -4,760	-3%	-$160K	0.43%	57
2021 Q2	$6.48M	Buy	186,785 +1,700	+0.9%	+$56.1K	0.45%	57
2021 Q1	$5.45M	Buy	185,085 +898	+0.5%	+$27.6K	0.42%	60
2020 Q4	$5.65M	Sell	184,187 -3,995	-2%	-$122K	0.46%	57
2020 Q3	$5.26M	Sell	188,182 -27,355	-13%	-$693K	0.51%	47
2020 Q2	$4.62M	Sell	215,537 -270,200	-56%	-$5.97M	0.49%	51
2020 Q1	$10.9M	Buy	485,737 +71,678	+17%	+$1.96M	1.37%	26
2019 Q4	$12.2M	Buy	414,059 +119,059	+40%	+$3.24M	1.05%	33
2019 Q3	$7.84M	Buy	+295,000	New	+$8.85M	0.73%	47